Literature DB >> 9230123

Fatty acyl-CoA-acyl-CoA-binding protein complexes activate the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum.

R Fulceri1, J Knudsen, R Giunti, P Volpe, A Nori, A Benedetti.   

Abstract

We previously reported that fatty acyl-CoA esters activate ryanodine receptor/Ca2+ release channels in a terminal cisternae fraction from rabbit skeletal muscle [Fulceri, Nori, Gamberucci, Volpe, Giunti and Benedetti (1994) Cell Calcium 15, 109-116]. Skeletal muscle cytosol contains a high-affinity fatty acyl-CoA-binding protein (ACBP) [Knudsen, Hojrup, Hansen, H.O., Hansen, H.F. and Roepstorff (1989) Biochem. J. 262, 513-519]. We show here that palmitoyl-CoA (PCoA) in a complex with a molar excess of bovine ACBP causes a discrete Ca2+ efflux or allows Ca2+ release from the Ca2+-preloaded terminal cisternae fraction by sub-optimal caffeine concentrations. Both effects were abolished by elevating the free [Mg2+] in the system, which inhibits the Ca2+ release channel activity. Sensitization towards caffeine was a function of both the concentration of the complex and the [PCoA]-to-[ACBP] ratio. In all experimental conditions the calculated free [PCoA] was no more than 50 nM, and such concentrations by themselves were inactive on Ca2+ release channels. The KD for PCoA binding was approx. 2 nM for bovine and yeast ACBP, and slightly higher (8 nM) for rat ACBP. The PCoA-rat ACBP complex behaved in the same manner as the PCoA-bovine ACBP complex, whereas the ester complexed with yeast ACBP was more active in activating/sensitizing Ca2+ efflux. A non-hydrolysable analogue of PCoA bound to (bovine) ACBP also sensitized the Ca2+ release channel towards caffeine. These findings indicate that fatty acyl-CoA-ACBP complexes either interact directly with one or more components in the terminal cisternae membranes or, through interaction with the component(s), donate the fatty acyl-CoA esters to high-affinity binding sites of the membrane, thus affecting (and possibly regulating) Ca2+ release channel activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230123      PMCID: PMC1218577          DOI: 10.1042/bj3250423

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Regulation of long chain fatty acid activation in heart muscle.

Authors:  J F Oram; J I Wenger; J R Neely
Journal:  J Biol Chem       Date:  1975-01-10       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Cellular retinol-binding protein-supported retinoic acid synthesis. Relative roles of microsomes and cytosol.

Authors:  M H Boerman; J L Napoli
Journal:  J Biol Chem       Date:  1996-03-08       Impact factor: 5.157

4.  Palmitoyl-CoA potentiates the Ca2+ release elicited by cyclic ADP-ribose.

Authors:  E N Chini; T P Dousa
Journal:  Am J Physiol       Date:  1996-02

5.  Activation of the sarcoplasmic reticulum Ca2+-ATPase induced by exercise.

Authors:  D A Ferrington; J C Reijneveld; P R Bär; D J Bigelow
Journal:  Biochim Biophys Acta       Date:  1996-03-13

6.  Thermodynamics of ligand binding to acyl-coenzyme A binding protein studied by titration calorimetry.

Authors:  N J Faergeman; B W Sigurskjold; B B Kragelund; K V Andersen; J Knudsen
Journal:  Biochemistry       Date:  1996-11-12       Impact factor: 3.162

7.  Fatty acid binding and conformational stability of mutants of human muscle fatty acid-binding protein.

Authors:  C F Prinsen; J H Veerkamp
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

8.  Effects of palmitoyl carnitine and related metabolites on the avian Ca(2+)-ATPase and Ca2+ release channel.

Authors:  E Dumonteil; H Barré; G Meissner
Journal:  J Physiol       Date:  1994-08-15       Impact factor: 5.182

9.  The membrane-perturbing properties of palmitoyl-coenzyme A and palmitoylcarnitine. A comparative study.

Authors:  M A Requero; F M Goñi; A Alonso
Journal:  Biochemistry       Date:  1995-08-22       Impact factor: 3.162

Review 10.  Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects.

Authors:  J R Mickelson; C F Louis
Journal:  Physiol Rev       Date:  1996-04       Impact factor: 37.312

View more
  5 in total

1.  Depletion of acyl-coenzyme A-binding protein affects sphingolipid synthesis and causes vesicle accumulation and membrane defects in Saccharomyces cerevisiae.

Authors:  B Gaigg; T B Neergaard; R Schneiter; J K Hansen; N J Faergeman; N A Jensen; J R Andersen; J Friis; R Sandhoff; H D Schrøder; J Knudsen
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Regulation of very-long acyl chain ceramide synthesis by acyl-CoA-binding protein.

Authors:  Natalia Santos Ferreira; Hanne Engelsby; Ditte Neess; Samuel L Kelly; Giora Volpert; Alfred H Merrill; Anthony H Futerman; Nils J Færgeman
Journal:  J Biol Chem       Date:  2017-03-19       Impact factor: 5.157

3.  Fluorescently labelled bovine acyl-CoA-binding protein acting as an acyl-CoA sensor: interaction with CoA and acyl-CoA esters and its use in measuring free acyl-CoA esters and non-esterified fatty acids.

Authors:  Majken C T Wadum; Jens K Villadsen; Søren Feddersen; Rikke S Møller; Thomas B F Neergaard; Birthe B Kragelund; Peter Højrup; Nils J Faergeman; Jens Knudsen
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

4.  Acyl-CoA binding proteins; structural and functional conservation over 2000 MYA.

Authors:  Nils J Faergeman; Majken Wadum; Søren Feddersen; Mark Burton; Birthe B Kragelund; Jens Knudsen
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

5.  Comprehensive Characterization of Toxoplasma Acyl Coenzyme A-Binding Protein TgACBP2 and Its Critical Role in Parasite Cardiolipin Metabolism.

Authors:  Yong Fu; Xia Cui; Sai Fan; Jing Liu; Xiao Zhang; Yihan Wu; Qun Liu
Journal:  mBio       Date:  2018-10-23       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.